These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36192736)

  • 1. 'It's the same thing as giving them CPR training': rural first responders' perspectives on naloxone.
    Filteau MR; Green B; Kim F; McBride KA
    Harm Reduct J; 2022 Oct; 19(1):111. PubMed ID: 36192736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of first responders' intention to refer to post-overdose services following SHIELD training.
    Siddiqui ST; La Manna A; Connors E; Smith R; Vance K; Budesa Z; Goulka J; Beletsky L; Wood CA; Marotta P; Winograd RP
    Harm Reduct J; 2024 Feb; 21(1):39. PubMed ID: 38351046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone administration by law enforcement officers in New York State (2015-2020).
    Pourtaher E; Payne ER; Fera N; Rowe K; Leung SJ; Stancliff S; Hammer M; Vinehout J; Dailey MW
    Harm Reduct J; 2022 Sep; 19(1):102. PubMed ID: 36123614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "That's why we're speaking up today": exploring barriers to overdose fatality prevention in Indianapolis' Black community with semi-structured interviews.
    Seo DC; Satterfield N; Alba-Lopez L; Lee SH; Crabtree C; Cochran N
    Harm Reduct J; 2023 Oct; 20(1):159. PubMed ID: 37891632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Opioid Overdose Resuscitation Education for Addiction Counselors and Trainees (Opioid Overdose REACT) naloxone response education pilot project improved confidence and knowledge among addiction counselors and trainees.
    Argenyi MS; Evans JK; Gay Y; Epstein DH; Weiss ST
    Clin Toxicol (Phila); 2023 Jul; 61(7):509-517. PubMed ID: 37427894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploratory study of a hands-on naloxone training for rural clinicians and staff.
    Cody SL; Hines CB; Glenn CJ; Sharp-Marbury R; Newman S
    J Nurs Scholarsh; 2023 May; 55(3):599-604. PubMed ID: 36411494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone access for Emergency Medical Technicians: An evaluation of a training program in rural communities.
    Zhang X; Marchand C; Sullivan B; Klass EM; Wagner KD
    Addict Behav; 2018 Nov; 86():79-85. PubMed ID: 29572041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review.
    Luna G; Dermid G; Unger JB
    Harm Reduct J; 2024 Aug; 21(1):150. PubMed ID: 39152433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Responders' Views of Naloxone: Does Stigma Matter?
    Kruis NE; McLean K; Perry P; Nackley MK
    Subst Use Misuse; 2022; 57(10):1534-1544. PubMed ID: 35791871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm Reduction in the Field: First Responders' Perceptions of Opioid Overdose Interventions.
    Elswick Fockele C; Frohe T; McBride O; Perlmutter DL; Goh B; Williams G; Wettemann C; Holland N; Finegood B; Oliphant-Wells T; Williams EC; van Draanen J
    West J Emerg Med; 2024 Jul; 25(4):490-499. PubMed ID: 39028235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
    Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It's what the community demands: Results of community-based emergency opioid overdose trainings.
    Febres-Cordero S; Smith DJ; Wulkan AZ; Béliveau AJ; Gish A; Zine S; Fugitt L; Giordano NA
    Public Health Nurs; 2023 Jan; 40(1):44-53. PubMed ID: 36377302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.
    Parkin S; Neale J; Brown C; Jones JD; Brandt L; Castillo F; Campbell ANC; Strang J; Comer SD
    Int J Drug Policy; 2021 Jan; 87():102968. PubMed ID: 33096365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient perceptions of higher-dose naloxone nasal spray for opioid overdose.
    Strickland JC; Marks KR; Smith KE; Ellis JD; Hobelmann JG; Huhn AS
    Int J Drug Policy; 2022 Aug; 106():103751. PubMed ID: 35636070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative examination of naloxone access in three states: Connecticut, Kentucky, and Wisconsin.
    Spector AL; Galletly CL; Christenson EA; Montaque HDG; Dickson-Gomez J
    BMC Public Health; 2022 Jul; 22(1):1387. PubMed ID: 35854278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for the design of overdose education and naloxone distribution interventions: results of a multi-stakeholder workshop.
    Sellen K; Markowitz B; Parsons JA; Leece P; Handford C; Goso N; Hopkins S; Klaiman M; Shahin R; Milos G; Wright A; Charles M; Morrison L; Strike C; Orkin A;
    BMC Public Health; 2023 May; 23(1):888. PubMed ID: 37189052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concerns that an opioid antidote could "make things worse": Profiles of risk compensation beliefs using the Naloxone-Related Risk Compensation Beliefs (NaRRC-B) scale.
    Winograd RP; Werner KB; Green L; Phillips S; Armbruster J; Paul R
    Subst Abus; 2020; 41(2):245-251. PubMed ID: 31170030
    [No Abstract]   [Full Text] [Related]  

  • 18. Decision-making by laypersons equipped with an emergency response smartphone app for opioid overdose.
    Ataiants J; Reed MK; Schwartz DG; Roth A; Marcu G; Lankenau SE
    Int J Drug Policy; 2021 Sep; 95():103250. PubMed ID: 33887699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lowering barriers to naloxone access through a student-led harm reduction program.
    Brown M; Tran C; Dadiomov D
    J Am Pharm Assoc (2003); 2023; 63(1):349-355. PubMed ID: 36443177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legal changes to increase access to naloxone for opioid overdose reversal in the United States.
    Davis CS; Carr D
    Drug Alcohol Depend; 2015 Dec; 157():112-20. PubMed ID: 26507172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.